Department of Error (DOI:10.1016/S0140-6736(07)60544-3);Clinical update: diagnosis and treatment of essential tremor

Lancet

Volumn 369, Issue 9568, 2007, Pages 1152-1154

  Benito León, Julián ^a   Louis, Elan D ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMIODARONE; ANTIDEPRESSANT AGENT; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; BRONCHODILATING AGENT; CINNARIZINE; CYCLOSPORIN; DOPAMINE TRANSPORTER; FLUNARIZINE; GABAPENTIN; LITHIUM; METHYLPHENIDATE; METOCLOPRAMIDE; NADOLOL; NEUROLEPTIC AGENT; PLACEBO; PREDNISONE; PRIMIDONE; PROCAINAMIDE; PROPRANOLOL; SOTALOL; TOPIRAMATE; VALPROIC ACID;

ANAMNESIS; ANXIETY DISORDER; ARTICLE; ASTHMA; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DIAGNOSTIC ERROR; DISABILITY; DIZZINESS; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; DYSTONIA; ESSENTIAL TREMOR; HUMAN; HYPERTENSION; HYPERTHYROIDISM; INTENTION TREMOR; KINETIC TREMOR; LABORATORY TEST; NEUROPHYSIOLOGY; PARKINSON DISEASE; PHYSICAL EXAMINATION; POSTURAL TREMOR; PRIORITY JOURNAL; REST TREMOR; TREMOR; UNSTEADINESS; WILSON DISEASE;

EID: 34047113792     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61293-8     Document Type: Erratum

References (18)

1. Benito-León J., and Louis E. Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2 (2006) 666-678
2. Jain S., Lo S., and Louis E. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?. Arch Neurol 63 (2006) 1100-1104
3. Shahed J., and Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 13 (2007) 67-76
4. Putzke J., Whaley N., Baba Y., Wszolek Z., and Uitti R. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 77 (2006) 1235-1237
5. Lorenz D., Schwieger D., Moises H., and Deuschl G. Quality of life and personality in essential tremor patients. Mov Disord 21 (2006) 1114-1118
6. Benito-León J., Louis E., Bermejo-Pareja F., and for the Neurological Disorders in Central Spain (NEDICES) study group. Population-based case-control study of cognitive function in essential tremor. Neurology 66 (2006) 69-74
7. Cleeves L., and Findley L. Propranolol and propranolol-LA in essential tremor: a double blind comparative study. J Neurol Neurosurg Psychiatry 51 (1988) 379-384
8. Findley L., Cleeves L., and Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 48 (1985) 911-915
9. Gorman W., Cooper R., Pocock P., and Campbell M. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 49 (1986) 64-68
10. Koller W., and Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 39 (1989) 1587-1588
11. Zesiewicz T., Elble R., Louis E., et al. Practice parameter: therapies for essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 64 (2005) 2008-2020
12. Leigh P., Jefferson D., Twomey A., et al. Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry 46 (1983) 710-715
13. Huber S., and Paulson G. Efficacy of alprazolam for essential tremor. Neurology 38 (1988) 241-243
14. Ondo W., Jankovic J., Connor G., et al. Topiramate in essential tremor. Neurology 66 (2006) 672-677
15. Ondo W., Hunter C., Dat Vuong K., Schwartz K., and Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord 15 (2000) 678-682
16. Brin M., Lyons K., Doucette J., et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology 56 (2001) 1523-1528
17. Schuurman P., Bosch D., Bossuyt P., et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342 (2000) 461-468
18. Pahwa R., Lyons K., Wilkinson S., et al. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg 104 (2006) 506-512